Abstract
A 2-year-old boy with influenza B infection and rapidly worsening targetoid skin lesions with mucosal involvement was diagnosed with Stevens–Johnson syndrome (SJS) and treated with oseltamivir and intravenous immunoglobulin, with resolution of illness. Subsequent quadrivalent inactivated influenza vaccine was well tolerated. This case highlights the rarity of SJS in the setting of influenza B infection and addresses the safety of administering subsequent influenza vaccines to such individuals.
from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2ljBXg5
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου